HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$16.33
Day range
$16.34 - $16.81
Year range
$14.55 - $32.59
Market cap
2.72B USD
Avg Volume
1.57M
P/E ratio
90.56
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 241.96M | 46.44% |
Operating expense | 117.06M | 21.98% |
Net income | 33.39M | 2,897.22% |
Net profit margin | 13.80 | 1,959.70% |
Earnings per share | 0.20 | 1,900.00% |
EBITDA | 33.01M | 587.24% |
Effective tax rate | 10.20% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 500.94M | 33.45% |
Total assets | 914.10M | 42.21% |
Total liabilities | 397.40M | 60.91% |
Total equity | 516.70M | — |
Shares outstanding | 165.88M | — |
Price to book | 5.23 | — |
Return on assets | 8.60% | — |
Return on capital | 13.86% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 33.39M | 2,897.22% |
Cash from operations | 25.01M | 205.00% |
Cash from investing | -56.19M | 71.08% |
Cash from financing | 3.56M | -34.92% |
Net change in cash | -27.61M | 84.71% |
Free cash flow | 21.32M | 128.54% |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
630